Histone deacetylation in epigenetics: an attractive target for anticancer therapy.
about
Expression of latent HIV induced by the potent HDAC inhibitor suberoylanilide hydroxamic acidEpigenetics in non-small cell lung cancer: from basics to therapeuticsEpigenetic diet: impact on the epigenome and cancerNatural Compound Histone Deacetylase Inhibitors (HDACi): Synergy with Inflammatory Signaling Pathway Modulators and Clinical Applications in CancerTargeting histone deacetylases: perspectives for epigenetic-based therapy in cardio-cerebrovascular diseasePTTG1 attenuates drug-induced cellular senescenceHDAC inhibition induces increased choline uptake and elevated phosphocholine levels in MCF7 breast cancer cellsExploration of Novel Inhibitors for Class I Histone Deacetylase Isoforms by QSAR Modeling and Molecular Dynamics Simulation AssaysHistone deacetylase 1/2 mediates proliferation of renal interstitial fibroblasts and expression of cell cycle proteinsHistone acetylation and steroid receptor coactivator expression during clofibrate-induced rat hepatocarcinogenesisDirected evolution of a histone acetyltransferase--enhancing thermostability, whilst maintaining catalytic activity and substrate specificity.NBM-T-L-BMX-OS01, Semisynthesized from Osthole, Is a Novel Inhibitor of Histone Deacetylase and Enhances Learning and Memory in RatsModulation of epigenetic targets for anticancer therapy: clinicopathological relevance, structural data and drug discovery perspectivesA proof-of-principle study of epigenetic therapy added to neoadjuvant doxorubicin cyclophosphamide for locally advanced breast cancer.Cell-Type Specific Determinants of NRAMP1 Expression in Professional PhagocytesEpigenetics and pancreatic cancer: pathophysiology and novel treatment aspectsEpigenetic Targeting of Transforming Growth Factor β Receptor II and Implications for Cancer TherapyThe histone deacetylase inhibitor valproic acid sensitizes human and canine osteosarcoma to doxorubicin.Phase I pharmacokinetic and pharmacodynamic evaluation of combined valproic acid/doxorubicin treatment in dogs with spontaneous cancer.Comparative gene expression profiling of P. falciparum malaria parasites exposed to three different histone deacetylase inhibitorsDesign, synthesis, and evaluation of hydroxamic acid-based molecular probes for in vivo imaging of histone deacetylase (HDAC) in brain.Histone deacetylase 9 activates gamma-globin gene expression in primary erythroid cellsSmall-molecular modulators of cancer-associated epigenetic mechanisms.Integrated transcriptomic and epigenomic analysis of primary human lung epithelial cell differentiation.Identification of highly selective and potent histone deacetylase 3 inhibitors using click chemistry-based combinatorial fragment assembly.HDAC inhibition and graft versus host diseaseOn the inhibition of histone deacetylase 8Cytotoxic effect of curcumin on malaria parasite Plasmodium falciparum: inhibition of histone acetylation and generation of reactive oxygen species.Delphinidin sensitizes prostate cancer cells to TRAIL-induced apoptosis, by inducing DR5 and causing caspase-mediated HDAC3 cleavage.Solid tumor differentiation therapy - is it possible?Epigenetic changes in cancer by Raman imaging, fluorescence imaging, AFM and scanning near-field optical microscopy (SNOM). Acetylation in normal and human cancer breast cells MCF10A, MCF7 and MDA-MB-231.Molecular mechanism of SAHA on regulation of autophagic cell death in tamoxifen-resistant MCF-7 breast cancer cells.The significance of epigenetic alterations in lung carcinogenesis.Enhanced Cytotoxic Effects of Combined Valproic Acid and the Aurora Kinase Inhibitor VE465 on Gynecologic Cancer Cells.Histone modifications and chromatin dynamics: a focus on filamentous fungi.The therapeutic uses of chromatin-modifying agents.Histone deacetylase inhibitors and hemoglobin F induction in beta-thalassemiaIsoform-selective histone deacetylase inhibitorsEpigenetic treatment of myelodysplastic syndromes and acute myeloid leukemias.Pharmacodynamic assessment of histone deacetylase inhibitors: infrared vibrational spectroscopic imaging of protein acetylation
P2860
Q24596282-3B57F678-7F09-4F84-924B-EC0D327ABBECQ26749113-9CB1C9CC-D0B1-491F-917D-F8756471FB0DQ27022002-4083F5C6-F617-4F94-9505-7000C6E01E01Q28073020-BE7F6322-EE52-46FA-B334-1C7D88ACC9E6Q28085588-FF6BA843-1BDA-49B8-93AD-603FF9D92F18Q28476617-685B4913-F993-4452-B922-39B52AF93ED9Q28486529-7F45CB6D-E0B6-4917-AE22-B5F7F98EF15CQ28550025-D44CC4BE-7258-4182-97C7-4C0202CA4D2AQ28571005-C4B3CAEF-0954-45A6-9EE1-3A978C8E495BQ28577672-8880E826-5343-4611-9BE4-BC5181BD05EEQ30373030-B1F63520-12DB-4C1B-A273-F60B0ED623C7Q30538837-22480435-DF2C-4672-8B7D-32DF5833C749Q30570945-CAC0FF29-50AE-4AF8-B04E-7B5235D51C5BQ33267359-1AA1FA2C-5AB8-46B0-A06C-01CAF72E4431Q33565416-DA24C41A-95EE-4F75-8C49-1C2984A70FE5Q33801377-B3D9FE74-32DE-4450-AF55-277BB49E0A05Q33802356-17AF8BA5-7399-4462-B9F1-8CDED6B95C75Q34044072-4CB969DF-37AA-499A-A677-E5435179A366Q34168530-32A27FDB-09A4-4662-A731-DE8F6CCA8E22Q34181991-3613B640-C560-46BC-A34F-2AF95FF0D54CQ34395031-862AC801-3906-4B6C-B8E4-72EFDC817AF5Q34503302-E3D7A97F-09B4-4AAC-AECB-D8B6A63E1817Q34628002-57DD37C4-EEEC-43A2-BBB3-02121A6270C8Q34789360-FB497CC1-3ADC-4659-B12D-106E877D9F90Q34850301-77AB691F-8BFB-4BB0-BEE8-2AE9C56AB65DQ35016985-79248064-84D9-4325-8381-2B45D8AB665DQ35633424-2BF88CB1-0BFA-4EE4-B262-4C86C76CD527Q35635984-FE974061-EFE5-41AA-ACD0-B2F06D594D7AQ35833213-E54B6D1F-BE3D-4E32-85F0-6D4B5CDB97D7Q36071880-FEB22322-621C-4CEC-BBDD-80A7BF5538BAQ36086535-01EBAB66-6C2B-4B02-BD28-ABFAB82E52DAQ36400882-E5655DCE-6881-4964-B206-10252C8DD18CQ36457427-23BAA3E8-5587-4360-9133-57862B07D1DAQ36700778-FE077ADA-4810-4481-9FCA-B38ADA1B0A90Q36742450-72301E0A-60D6-4105-BAFC-23D05193DEAAQ36822457-A909DE96-D6EA-4E36-A9B2-3BA79522345AQ36968042-D5D07528-9EE0-4298-9392-7FFA71468867Q36995048-ED9B63D6-2CD6-4C08-8F6A-2CF7ABF0D993Q37184917-30D838FB-2826-4EC9-98B0-D0C0D45E977DQ37199052-841C28A6-8D9D-48EC-89AB-0420FBA6FAC9
P2860
Histone deacetylation in epigenetics: an attractive target for anticancer therapy.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Histone deacetylation in epigenetics: an attractive target for anticancer therapy.
@ast
Histone deacetylation in epigenetics: an attractive target for anticancer therapy.
@en
type
label
Histone deacetylation in epigenetics: an attractive target for anticancer therapy.
@ast
Histone deacetylation in epigenetics: an attractive target for anticancer therapy.
@en
prefLabel
Histone deacetylation in epigenetics: an attractive target for anticancer therapy.
@ast
Histone deacetylation in epigenetics: an attractive target for anticancer therapy.
@en
P2093
P50
P356
P1476
Histone deacetylation in epigenetics: an attractive target for anticancer therapy.
@en
P2093
Ilaria Cerbara
Riccardo Pezzi
Silvia Simeoni
Silvio Massa
P304
P356
10.1002/MED.20024
P577
2005-05-01T00:00:00Z